Items tagged with Scientific research
Double X-ray vision helps TB and osteoporosis research (post)
With an advanced X-ray combination technique, scientists have traced nanocarriers for tuberculosis drugs within cells with very high precision. The method combines two sophisticated scanning X-ray measurements and can locate minute amounts of various metals in biological samples at very high resolution, as a team around DESY scientist Karolina Stachnik reports in the journal Scientific Reports. To illustrate its versatility, the researchers have also used the combination method to map the calcium content in human bone, an analysis that can benefit osteoporosis research.
Recent advances in addressing TB give hope for future (post)
In September 2018, the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis (TB). TB is a bacterial disease that has claimed the lives of more than a billion people in the past two centuries. Now, a new “Perspective” in The Journal of Infectious Diseases by NIAID Director Anthony S. Fauci, M.D., and other Institute officials summarizes recent progress in improved TB diagnostics, therapeutic regimens and prevention approaches that made 2019 a “banner year” for TB research.
Bacteria under the microscope: a new growth model for TB (post)
New research has shed light on how mycobacteria grow. This discovery could explain why some members of this family of single-celled organisms, which includes the bacillus that causes tuberculosis, can develop resistance to antibiotics.
New experimental system proves tuberculosis bacteria have friends and foes in vivo (post)
Dr. David Russell, the William Kaplan Professor of Infection Biology in the Department of Microbiology and Immunology in the Cornell College of Veterinary Medicine, has used a cutting-edge method for illuminating the interaction between the bacteria that cause tuberculosis and two different kinds of host cells.
Artificial intelligence discovers potent antibiotic (post)
Researchers used a machine-learning platform to test more than 100 million molecules for antibacterial activity.
First-of-its-kind global collaboration launched to develop transformative treatment regimens for TB (post)
-- A new global collaboration of philanthropic, non-profit and private sector organizations will work together to accelerate the development of novel TB treatment regimens for all TB patients.
-- The global collaboration aims to create treatment regimens comprised of medicines to which there is limited or no drug resistance and that are ready for phase 3 development.
-- The regimens could be an important step toward addressing the current global challenges around TB treatment complexity, and the diagnosis and treatment of drug-resistant TB.
Hydrogen sulfide heightens disease in TB, suggesting a new therapeutic target (post)
A new culprit — hydrogen sulfide — has been found for the deadly infectious disease tuberculosis. Hydrogen sulfide gas is known for its rotten egg smell, yet it has normal physiological roles in the human body to communicate among cells.
Page 46 of 74 · Total posts: 0
←First 45 46 47 Last→